Genmab A/S
CSE:GMAB
Genmab A/S
CSE:GMAB
Price:
1 641
DKK
-0.88%
Market Closed
Market Cap:
kr105.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Genmab A/S
CSE:GMAB
|
DK |
|
Johnson Electric Holdings Ltd
HKEX:179
|
HK |
|
Yonyou Network Technology Co Ltd
SSE:600588
|
CN |
|
J
|
Jay Bharat Maruti Ltd
NSE:JAYBARMARU
|
IN |
|
Aviva PLC
LSE:AV
|
UK |
|
Cogobuy Group
HKEX:400
|
CN |
|
WDB Holdings Co Ltd
TSE:2475
|
JP |
|
Nippon Concrete Industries Co Ltd
TSE:5269
|
JP |
|
Shijiazhuang Tonhe Electronics Technologies Co Ltd
SZSE:300491
|
CN |
Relative Value
The Relative Value of one
GMAB
stock under the Base Case scenario is
hidden
DKK.
Compared to the current market price of 1 641 DKK,
Genmab A/S
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GMAB Relative Value
HIDDEN
Multiples Across Competitors
GMAB Competitors Multiples
Genmab A/S Competitors
Genmab A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Genmab A/S
CSE:GMAB
|
102B DKK | 27.2 | 105 | 78.1 | 82.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.7 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 28.8 | 21.6 | 22.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.5 | 17.4 | 12.8 | 14.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36B EUR | 10.1 | 32.5 | 35 | 35.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
